DE3779909T2 - In-vitro-testverfahren zum nachweis zellulaerer immunresponsen. - Google Patents

In-vitro-testverfahren zum nachweis zellulaerer immunresponsen.

Info

Publication number
DE3779909T2
DE3779909T2 DE8787901300T DE3779909T DE3779909T2 DE 3779909 T2 DE3779909 T2 DE 3779909T2 DE 8787901300 T DE8787901300 T DE 8787901300T DE 3779909 T DE3779909 T DE 3779909T DE 3779909 T2 DE3779909 T2 DE 3779909T2
Authority
DE
Germany
Prior art keywords
immune responses
test procedure
cellular immune
vitro test
detecting cellular
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8787901300T
Other languages
English (en)
Other versions
DE3779909D1 (de
Inventor
Richard Wood
Austin Corner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Commonwealth Scientific and Industrial Research Organization CSIRO
Original Assignee
Commonwealth Scientific and Industrial Research Organization CSIRO
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Commonwealth Scientific and Industrial Research Organization CSIRO filed Critical Commonwealth Scientific and Industrial Research Organization CSIRO
Application granted granted Critical
Publication of DE3779909D1 publication Critical patent/DE3779909D1/de
Publication of DE3779909T2 publication Critical patent/DE3779909T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G01N33/6866—Interferon
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/811—Interferon
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/863—Mycobacterium
DE8787901300T 1986-03-06 1987-03-05 In-vitro-testverfahren zum nachweis zellulaerer immunresponsen. Expired - Lifetime DE3779909T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPH489386 1986-03-06
PCT/AU1987/000061 WO1987005400A1 (en) 1986-03-06 1987-03-05 In vitro assay for detecting cell-mediated immune responses

Publications (2)

Publication Number Publication Date
DE3779909D1 DE3779909D1 (de) 1992-07-23
DE3779909T2 true DE3779909T2 (de) 1993-01-07

Family

ID=3771495

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8787901300T Expired - Lifetime DE3779909T2 (de) 1986-03-06 1987-03-05 In-vitro-testverfahren zum nachweis zellulaerer immunresponsen.

Country Status (8)

Country Link
US (2) US5334504A (de)
EP (1) EP0296158B1 (de)
JP (1) JP2642112B2 (de)
AT (1) ATE77488T1 (de)
AU (1) AU595021B2 (de)
CA (1) CA1299099C (de)
DE (1) DE3779909T2 (de)
WO (1) WO1987005400A1 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5766920A (en) * 1982-08-11 1998-06-16 Cellcor, Inc. Ex vivo activation of immune cells
DE3779909T2 (de) * 1986-03-06 1993-01-07 Commw Scient Ind Res Org In-vitro-testverfahren zum nachweis zellulaerer immunresponsen.
IE62428B1 (en) * 1988-03-31 1995-02-08 Commw Scient Ind Res Org Diagnosis of mycobacterium bovis infection
US5693500A (en) * 1988-03-31 1997-12-02 Commonwealth Scientific And Industrial Research Organisation Diagnosis of Mycobacterium bovis infection
CA2011099A1 (en) * 1989-04-19 1990-10-19 Stephen C. Wardlaw Determination of lymphocyte reactivity to specific antigens in blood
EP0443036B1 (de) * 1989-09-08 1995-09-13 YAMAUCHI, Tamio Verfahren zur bestimmung der kinetik der immunität
US5639623A (en) * 1989-09-08 1997-06-17 Yamauchi; Tamio Method of measuring immunokinetics
EP0539610A1 (de) * 1991-10-26 1993-05-05 Torf Establishment Verfahren und Zusammensetzung zur Bestimmung der Immunologischen Aktivität von aktiven Substanzen enthaltende Lösungen
US5583713A (en) * 1994-07-22 1996-12-10 Analog Devices, Inc. Pipelined demodulation and ADC conversion scheme for disk drive servo system
US5750356A (en) * 1996-05-31 1998-05-12 Anergen, Inc. Method for monitoring T cell reactivity
GB9624456D0 (en) 1996-11-25 1997-01-15 Isis Innovation Assay method
DE19835721A1 (de) 1998-08-07 2000-02-10 Edi Experimentelle & Diagnosti Verfahren zur Bestimmung der Immunabwehr des Blutes sowie Testkit hierfür und Verwendung eines geeigneten Spritzenzylinders
US6297015B1 (en) * 1998-09-24 2001-10-02 Ira Shafran Crohn's disease diagnostic and treatment methods and compositions
US6150121A (en) * 1999-02-16 2000-11-21 Wisconsin Alumni Research Foundation Assessing immunological state of transplant recipients
US6316205B1 (en) * 2000-01-28 2001-11-13 Genelabs Diagnostics Pte Ltd. Assay devices and methods of analyte detection
WO2003052424A2 (en) * 2001-12-14 2003-06-26 Cambridge University Technical Services Limited Methods and means for modulating the immune response
AU2002952548A0 (en) * 2002-11-08 2002-11-21 Cellestis Limited Diagnostic assay
US7638271B2 (en) * 2003-07-31 2009-12-29 ICDDR, B: The Center for Health and Population Research Use of antibody from lymphocyte secretions to diagnose active infection
JP5700934B2 (ja) * 2007-03-16 2015-04-15 セルスティス リミテッド 細胞性免疫反応アッセイおよびそのためのキット
EP3269379A1 (de) 2008-11-30 2018-01-17 Immusant, Inc. Zusammensetzungen und verfahren zur behandlung von zöliakie
US9968666B2 (en) 2009-06-12 2018-05-15 Vaccine Technologies, Incorporated Methods and compositions for promoting a cell-mediated immune response
WO2010144794A1 (en) 2009-06-12 2010-12-16 Vaccine Technologies, Incorporated Baculovirus-expressed fusion polypeptide vaccines with enhanced immunogenicity and uses thereof
WO2011146968A1 (en) * 2010-05-28 2011-12-01 Cellestis Limited A diagnostic assay
ITRM20100411A1 (it) * 2010-07-23 2012-01-24 Massimo Amicosante Uso di sequenze amminoacidiche da mycobacterium tuberculosis o dei loro corrispondenti acidi nucleici per la diagnosi e la prevenzione di infezione tubercolare, relativo kit diagnostico e vaccino.
CA2900008A1 (en) 2013-02-07 2014-08-14 Children's Medical Center Corporation Protein antigens that provide protection against pneumococcal colonization and/or disease
CA2923822A1 (en) 2013-09-10 2015-03-19 Immusant, Inc. Dosage of a gluten peptide composition
CA2946869A1 (en) 2014-04-24 2015-10-29 Immusant, Inc. Methods for diagnosing celiac disease using circulating cytokines/chemokines
US10370718B2 (en) 2014-09-29 2019-08-06 Immusant, Inc. Use of HLA genetic status to assess or select treatment of celiac disease
KR101665849B1 (ko) * 2015-01-29 2016-10-12 사단법인대한결핵협회 결핵감염 진단을 위한 항원 펩타이드 조성물 및 이의 용도

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3969497A (en) * 1971-05-05 1976-07-13 Lincoln Laboratories, Inc. Test substance for tuberculosis
GB1443425A (en) * 1972-10-25 1976-07-21 Searle & Co Interferon assay
US4745053A (en) * 1983-07-08 1988-05-17 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyojo Process for producing human interferon and method for assaying the interferon productivity of blood
EP0132754B1 (de) * 1983-07-29 1991-03-27 The Rockefeller University Verwendung von Gamma-Interferon zur Herstellung eines Wirkstoffes in der Behandlung von Lepra
US4666865A (en) * 1984-01-13 1987-05-19 Centocor, Inc. Immunoassay for biologically active human interferon-gamma employing unique monoclonal antibodies
US4675282A (en) * 1984-07-06 1987-06-23 Damon Biotech, Inc. Assay for interferon epsilon
GB8418828D0 (en) * 1984-07-24 1984-08-30 Lab Ltd Ab Ag Calf screening
US4708937A (en) * 1984-10-15 1987-11-24 Brigham & Women's Hospital Purified migration inhibitory factor also having colony stimulating factor activity
US4689397A (en) * 1985-08-12 1987-08-25 Scripps Clinic And Research Foundation Synthetic polypeptides for detecting mycobacterial infections
DE3779909T2 (de) * 1986-03-06 1993-01-07 Commw Scient Ind Res Org In-vitro-testverfahren zum nachweis zellulaerer immunresponsen.
US4976958A (en) * 1987-02-26 1990-12-11 Scripps Clinic And Research Foundation Mycobacterial recombinants and peptides

Also Published As

Publication number Publication date
JP2642112B2 (ja) 1997-08-20
AU595021B2 (en) 1990-03-22
EP0296158B1 (de) 1992-06-17
EP0296158A4 (de) 1989-10-04
JPS63502695A (ja) 1988-10-06
DE3779909D1 (de) 1992-07-23
US5494799A (en) 1996-02-27
US5334504A (en) 1994-08-02
AU7165987A (en) 1987-09-28
EP0296158A1 (de) 1988-12-28
CA1299099C (en) 1992-04-21
WO1987005400A1 (en) 1987-09-11
ATE77488T1 (de) 1992-07-15

Similar Documents

Publication Publication Date Title
ATE77488T1 (de) In-vitro-testverfahren zum nachweis zellulaerer immunresponsen.
EP0140379A3 (en) Method and apparatus for measuring the degree of reaction between antigens and leukocyte cellular antibodies
DE3650150T2 (de) Modulator der anabolischen Aktivität und seine Verwendungen.
FI98961B (fi) Menetelmät ja määritysvälineet parodontaalisairauden aktiivisuuden ja/tai peri-implantiitin ja/tai niiden kohonneen riskin diagnosoimiseksi
IT1111074B (it) Reagente per prove immunologiche e procedimento per la sua preparazione
IT1083606B (it) Contenitore particolarmente provetta per analisi o procedure immuno chomiche ed enzimatiche e procedimento per la sua fabbricazione
ES454276A1 (es) Perfeccionamientos en un dispositivo para detectar la gona- dotropina corionica humana o su subunidad beta en la orina oel suero en la prueba de embarazo.
IL112146A0 (en) Test device and method for the detection of protein in a biological sample
NO161287C (no) Homogen immunologisk analysemetode, reagensmidler og proeveinnretning for bruk ved immunoanalysebestemmelse.
DE2964944D1 (en) A serological method for determining the presence of neisseria gonorrhoeae antibodies in human serum, a species-specific heat stable antigen to be used in this method and a method for the preparation of that antigen
IT8521902A0 (it) Procedimento e dispositivo per la misurazione degli spessori sui pezzi in prova mediante ultrasuoni.
JPS5294418A (en) Diluent for measuring rubella hi antibody
GB1385087A (en) Antigenic substance for testing for tuberculosis
DK414386D0 (da) Monoklonalt antistof, cellelinje til fremstilling deraf og antistoffets anvendelse
DK104988D0 (da) Fremgangsmaade og apparat til kvalitativ og/eller kvantitativ analyse af antigener, antistoffer, mikroorganismer eller andre celler
JPS5218815A (en) Novel method of immunological clinical diagnosis by means of gel-preci pitation
ES385489A1 (es) Procedimiento de prueba de diagnostico para la indicacion selectiva de la hepatitis.
JPS5772063A (en) Detection method for hepatitis b virus e antigen
GB1514639A (en) Test method to determine pulmonary embolism
IT7830061A0 (it) Metodo radioimmunologico per la determinazione della funzione tiroidea mediante un saggio in vitro su siero del sangue.
SU1336703A1 (ru) Способ определения соотношения делящихся и спонтанно делящихся нуклидов в изделиях
Bakulin et al. Method for the preparation of erythrocytic diagnostic reagent for detecting type A Clostridium perfringens enterotoxin.
SU1471837A1 (ru) Способ определения закономерностей ползучести материалов
ES8608321A1 (es) Hibridomas productores de anticuerpos monoclonales especifi-cos para la inmunoglobulina e (ige)humana del mieloma ns
MX9204271A (es) Prueba inmunoenzimatica para deteccion de anticuerpo vih-1.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition